This one is a roll of the dice really. I trust no opinions on these boards. I don't know what all the angst about the split is since it really should have been priced in a while back. I like to pay attention to what these companies are not saying. That the company hasn't decided to split the stock at this point when the view from the outside it is expected. Could be interpreted as half full the possibility that they won't need it? Substantial news could run this past a buck easily. He77, I see people flipping tickers that I have verified to be scams through the filings.
Everything that I post is just my informed opinion and is simply an invitation to debate. Trade on your own due diligence please..
Recent ADTX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 08:35:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/23/2026 08:30:42 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/22/2026 04:15:21 AM
- Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients • Business Wire • 04/20/2026 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2026 12:00:13 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/11/2026 01:49:19 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/07/2026 08:02:58 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/03/2026 08:37:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 01:13:36 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:35:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 12:00:37 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/27/2026 09:02:12 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/24/2026 09:21:36 PM
- Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer • Business Wire • 03/19/2026 12:15:00 PM
- Aditxt Acquires Ignite Proteomics to Expand Precision Oncology Capabilities • IH Market News • 03/13/2026 03:36:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 12:35:24 PM
- Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection • Business Wire • 03/13/2026 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:30:35 PM
- Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026 • Business Wire • 03/05/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 10:03:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2026 09:23:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2026 01:00:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 10:00:02 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/16/2025 10:00:03 PM
